Fact CheckerSign in

NCT07585331Completed

Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

Through an observational clinical study, partly prospective and partly retrospective, based on the collection of clinical data and on in vitro experimental analyses carried out on residual biological samples obtained during routine clinical procedures, it is proposed to identify predictive biomarkers of in vivo response to first-line therapies.

Status (registry)
Completed
Study type
Observational
Enrollment
250 (actual)
First submitted
7 May 2026
Start date
13 Jan 2022
Primary completion date
30 Mar 2026
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Diseases
Amyloidosis
NCT number
NCT07585331

What you commit to

  • Study type: Observational
  • Participants enrolled: 250
  • From 13 Jan 2022 to the primary completion date, 30 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous anti-plasma cell therapy

Other illness

  • Failure to show willingness to allow use of clinical data and diagnostic leftovers of clinical specimens for research purposes.

Age

  • Age \<18 years

Other

  • Non-AL amyloidosis
  • IgM clone

Who the study is looking for

  • Biopsy-proven systemic AL amyloidosis
  • No IgM clone
  • No history of anti-plasma cell therapy
  • Diagnostic bone marrow aspiration at ARTC
  • Age \> 18 years
  • Willingness to allow use of clinical data and diagnostic leftovers of clinical specimens for research purposes through signing a written informed consent.

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondazione IRCCS Policlinico San Matteo
Coordinator of this site? Confirm its status
PaviaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.